BG-12 Multiple Sclerosis treatment meets study goals

Discuss Tecfidera (BG-12, dimethyl fumarate) as an oral treatment for multiple sclerosis.

BG-12 Multiple Sclerosis treatment meets study goals

Postby MSUK » Mon Apr 11, 2011 5:57 am

Image

A Phase 3 trial of Biogen Idec Inc.'s multiple sclerosis treatment BG- 12 met the primary endpoint of reducing the number of patients who relapsed at two years when compared with a placebo.

The investigational oral compound, dimethyl fumarate, also met secondary targets, including lower ... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1679
MS-UK - http://www.ms-uk.org/
User avatar
MSUK
Family Elder
 
Posts: 2212
Joined: Wed Oct 14, 2009 2:00 pm

Advertisement

Return to Tecfidera (BG-12, dimethyl fumarate)

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users


Contact us | Terms of Service